UB Paderborn / Katalog / Suche / in CDI

Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia

The New England journal of medicine, 2002-03, Vol.346 (10), p.747-750

2002

Volltextzugriff (PDF)

A Nosocomial Outbreak of Fluoroquinolone-Resistant Streptococcus pneumoniae

Clinical infectious diseases, 2001-08, Vol.33 (4), p.517-522

2001

Volltextzugriff (PDF)

Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance

Emerging infectious diseases, 2003-07, Vol.9 (7), p.833-837

2003

Volltextzugriff (PDF)

Description of Staphylococcus Serine Protease (ssp) Operon in Staphylococcus aureus and Nonpolar Inactivation of sspA-Encoded Serine Protease

Infection and Immunity, 2001-01, Vol.69 (1), p.159-169

2001

Volltextzugriff (PDF)

Streptolysin S and necrotising infections produced by group G streptococcus

The Lancet (British edition), 2002-01, Vol.359 (9301), p.124-129

2002

Volltextzugriff (PDF)

Role for sagA and siaA in Quorum Sensing and Iron Regulation in Streptococcus pyogenes

Infection and Immunity, 2007-10, Vol.75 (10), p.5011-5017

2007

Volltextzugriff (PDF)

Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae : Contributions of type II topoisomerase mutations and efflux to levels of resistance

Antimicrobial agents and chemotherapy, 2000-11, Vol.44 (11), p.3049-3054

2000

Volltextzugriff (PDF)

Regulation of sagA, siaA and scpC by SilCR, a putative signaling peptide of Streptococcus pyogenes

FEMS microbiology letters, 2008-12, Vol.289 (2), p.119-125

2008

Volltextzugriff (PDF)

Identification of Group A Streptococcus Antigenic Determinants Upregulated In Vivo

Infection and Immunity, 2005-09, Vol.73 (9), p.6026-6038

2005

Volltextzugriff (PDF)

Identification of a Streptolysin S-Associated Gene Cluster and Its Role in the Pathogenesis of Streptococcus iniae Disease

Infection and Immunity, 2002-10, Vol.70 (10), p.5730-5739

2002

Volltextzugriff (PDF)

Streptococcus iniae Virulence Is Associated with a Distinct Genetic Profile

Infection and Immunity, 2001-04, Vol.69 (4), p.1994-2000

2001

Volltextzugriff (PDF)

Novel Murine Model of Pneumococcal Pneumonia: Use of Temperature as a Measure of Disease Severity To Compare the Efficacies of Moxifloxacin and Levofloxacin

Antimicrobial Agents and Chemotherapy, 2004-09, Vol.48 (9), p.3343-3348

2004

Volltextzugriff (PDF)

Genetic Locus for Streptolysin S Production by Group A Streptococcus

Infection and Immunity, 2000-07, Vol.68 (7), p.4245-4254

2000

Volltextzugriff (PDF)

Prevalence and Characterization of Invasive Isolates of Streptococcus pyogenes with Reduced Susceptibility to Fluoroquinolones

Antimicrobial Agents and Chemotherapy, 2005-05, Vol.49 (5), p.2130-2132

2005

Volltextzugriff (PDF)

Is In Vitro Antibiotic Combination More Effective than Single-Drug Therapy against Anthrax?

Antimicrobial Agents and Chemotherapy, 2005-04, Vol.49 (4), p.1323-1325

2005

Volltextzugriff (PDF)

Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance

Journal of antimicrobial chemotherapy, 2004-07, Vol.54 (1), p.90-94

2004

Volltextzugriff (PDF)

Interspecies Recombination Contributes Minimally to Fluoroquinolone Resistance in Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy, 2001-09, Vol.45 (9), p.2631-2634

2001

Volltextzugriff (PDF)

Evaluation of Susceptibility Testing To Detect Fluoroquinolone Resistance Mechanisms in Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy, 2001-06, Vol.45 (6), p.1911-1914

2001

Volltextzugriff (PDF)

two-component system sivS/R regulates virulence in Streptococcus iniae

FEMS immunology and medical microbiology, 2007-12, Vol.51 (3), p.547-554

2007

Volltextzugriff (PDF)

Capsule expression regulated by a two-component signal transduction system in Streptococcus iniae

FEMS immunology and medical microbiology, 2007-08, Vol.50 (3), p.366-374

2007

Volltextzugriff (PDF)

Quinolone Resistance: Older Concepts and Newer Developments

Current infectious disease reports, 2001-02, Vol.3 (1), p.20-28

2001

Volltextzugriff (PDF)

Fluoroquinolone Resistance in Clinical Isolates ofStreptococcus pneumoniae: Contributions of Type II Topoisomerase Mutations and Efflux to Levels of Resistance

Antimicrobial Agents and Chemotherapy, 2000-11, Vol.44 (11), p.3049-3054

2000

Volltextzugriff (PDF)

Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia

The New England journal of medicine, 2002-07, Vol.347 (1), p.65-67

2002

Volltextzugriff (PDF)

Short-course Gemifloxacin Therapy is Effective Against Streptococcus pneumoniae in a Murine Model of Pneumonia

Chest, 2004-10, Vol.126 (4), p.847S-847S

2004

Volltextzugriff (PDF)

Short-Course Therapy of Gemifloxacin Effective Against Pneumococcal Pneumonia in Mice

Journal of chemotherapy (Florence), 2006-12, Vol.18 (6), p.634-640

2006

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia

A Nosocomial Outbreak of Fluoroquinolone-Resistant Streptococcus pneumoniae

Antimicrobial susceptibility breakpoints and first-step parC mutations in Streptococcus pneumoniae: redefining fluoroquinolone resistance

Description of Staphylococcus Serine Protease (ssp) Operon in Staphylococcus aureus and Nonpolar Inactivation of sspA-Encoded Serine Protease

Streptolysin S and necrotising infections produced by group G streptococcus

Role for sagA and siaA in Quorum Sensing and Iron Regulation in Streptococcus pyogenes

Fluoroquinolone resistance in clinical isolates of Streptococcus pneumoniae : Contributions of type II topoisomerase mutations and efflux to levels of resistance

Regulation of sagA, siaA and scpC by SilCR, a putative signaling peptide of Streptococcus pyogenes

Identification of Group A Streptococcus Antigenic Determinants Upregulated In Vivo

Identification of a Streptolysin S-Associated Gene Cluster and Its Role in the Pathogenesis of Streptococcus iniae Disease

Streptococcus iniae Virulence Is Associated with a Distinct Genetic Profile

Novel Murine Model of Pneumococcal Pneumonia: Use of Temperature as a Measure of Disease Severity To Compare the Efficacies of Moxifloxacin and Levofloxacin

Genetic Locus for Streptolysin S Production by Group A Streptococcus

Prevalence and Characterization of Invasive Isolates of Streptococcus pyogenes with Reduced Susceptibility to Fluoroquinolones

Is In Vitro Antibiotic Combination More Effective than Single-Drug Therapy against Anthrax?

Type II topoisomerase mutations in Bacillus anthracis associated with high-level fluoroquinolone resistance

Interspecies Recombination Contributes Minimally to Fluoroquinolone Resistance in Streptococcus pneumoniae

Evaluation of Susceptibility Testing To Detect Fluoroquinolone Resistance Mechanisms in Streptococcus pneumoniae

two-component system sivS/R regulates virulence in Streptococcus iniae

Capsule expression regulated by a two-component signal transduction system in Streptococcus iniae

Quinolone Resistance: Older Concepts and Newer Developments

Fluoroquinolone Resistance in Clinical Isolates ofStreptococcus pneumoniae: Contributions of Type II Topoisomerase Mutations and Efflux to Levels of Resistance

Resistance to Levofloxacin and Failure of Treatment of Pneumococcal Pneumonia

Short-course Gemifloxacin Therapy is Effective Against Streptococcus pneumoniae in a Murine Model of Pneumonia

Short-Course Therapy of Gemifloxacin Effective Against Pneumococcal Pneumonia in Mice

Suchergebnisse filtern